Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 41, 2006 - Issue 10
Submit an article Journal homepage
208
Views
19
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Effect of rabeprazole and omeprazole on the onset of gastro-oesophageal reflux disease symptom relief during the first seven days of treatment

Peter Bytzer Department of Medical Gastroenterology, Glostrup University Hospital, Glostrup, DenmarkCorrespondence[email protected]
, PhD , MD,
Anna Morocutti Eisai Ltd., London, United Kingdom
,
Peter Kennerly Janssen Pharmaceutica NV, Beerse, Belgium
,
Miroslav Ravic Eisai Ltd., London, United Kingdom
,
Neil Miller Eisai Ltd., London, United Kingdom
&
ON BEHALF OF THE ROSE TRIAL INVESTIGATORS Department of Medical Gastroenterology, Glostrup University Hospital, Glostrup, Denmark
Pages 1132-1140 | Received 25 Oct 2005, Published online: 08 Jul 2009

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Stefano Pallotta, Fabio Pace & Silvia Marelli. (2008) Rabeprazole: a second-generation proton pump inhibitor in the treatment of acid-related disease. Expert Review of Gastroenterology & Hepatology 2:4, pages 509-522.
Read now

Articles from other publishers (18)

Asif Hossain Anik, Farhana Alam Proma, Pranoy Saha & Sabarni Sarker. (2024) Tegoprazan as a New Remedy for Gastrointestinal Diseases in Comparison with its Therapeutic Predecessors: A Mini-Review. Current Drug Research Reviews 16:1, pages 11-17.
Crossref
Koji Nakada, Atsushi Oshio, Nobuyuki Matsuhashi, Katsuhiko Iwakiri, Takeshi Kamiya, Noriaki Manabe, Takashi Joh, Kazuhide Higuchi & Ken Haruma. (2022) Causal effect of anxiety and depression status on the symptoms of gastroesophageal reflux disease and functional dyspepsia during proton pump inhibitor therapy. Esophagus 20:2, pages 309-316.
Crossref
Ji-Young Jeon, Sun-Young Kim, Seol Ju Moon, Kyeongmin Oh, Jiwon Lee, Bongtae Kim, Geun Seog Song & Min-Gul Kim. (2021) Pharmacokinetic Interactions between Tegoprazan and Metronidazole/Tetracycline/Bismuth and Safety Assessment in Healthy Korean Male Subjects. Clinical Therapeutics 43:4, pages 722-734.
Crossref
Maiko Ogawa, Seiji Arihiro, Nobuyuki Matsuhashi, Takashi Joh, Kazuhide Higuchi, Katsuhiko Iwakiri, Takeshi Kamiya, Noriaki Manabe, Kimio Isshi, Tatsuya Nakada, Atsushi Hokari, Masayuki Saruta, Atsushi Oshio, Ken Haruma & Koji Nakada. (2020) The early therapeutic response at 2 weeks is a crucial predictor of proton pump inhibitor-refractory gastroesophageal reflux disease. Esophagus 18:2, pages 398-406.
Crossref
Amy C. Engevik, Izumi Kaji & James R. Goldenring. (2020) The Physiology of the Gastric Parietal Cell. Physiological Reviews 100:2, pages 573-602.
Crossref
Tadayuki Oshima, Eitatsu Arai, Masato Taki, Takashi Kondo, Toshihiko Tomita, Hirokazu Fukui, Jiro Watari & Hiroto Miwa. (2019) Randomised clinical trial: vonoprazan versus lansoprazole for the initial relief of heartburn in patients with erosive oesophagitis. Alimentary Pharmacology & Therapeutics 49:2, pages 140-146.
Crossref
Tadayuki Oshima & Hiroto Miwa. (2018) Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases. Journal of Neurogastroenterology and Motility 24:3, pages 334-344.
Crossref
Richard Raedsch, Bettina Vinson, Bertram Ottillinger & Gerald Holtmann. (2017) Early onset of efficacy in patients with functional and motility-related gastrointestinal disordersFrühzeitiger Wirkungsbeginn bei Patienten mit funktionellen und motilitätsbedingten gastrointestinalen Erkrankungen. Wiener Medizinische Wochenschrift 168:3-4, pages 89-98.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 1040 1045 .
Akihito Nagahara, Tsuyoshi Suzuki, Naoyoshi Nagata, Nozomu Sugai, Yoshiaki Takeuchi, Kouichi Sakurai, Masaki Miyamoto, Kazuhiko Inoue, Junichi Akiyama, Katsuhiro Mabe, Ichiro Konuma, Tomoari Kamada & Ken Haruma. (2013) A multicentre randomised trial to compare the efficacy of omeprazole versus rabeprazole in early symptom relief in patients with reflux esophagitis. Journal of Gastroenterology 49:12, pages 1536-1547.
Crossref
X. M. Xia & H. Wang. (2013) Gastroesophageal Reflux Disease Relief in Patients Treated with Rabeprazole 20   mg versus Omeprazole 20   mg: A Meta-Analysis . Gastroenterology Research and Practice 2013, pages 1-6.
Crossref
Gerald Holtmann, Marc-André Bigard, Peter Malfertheiner & Roy Pounder. (2011) Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD. International Journal of Clinical Pharmacy 33:3, pages 493-500.
Crossref
Motoyasu KusanoShikou KuribayashiOsamu KawamuraYasuyuki ShimoyamaHiroko HosakaAtsuto NagoshiHiroaki ZaiMasatomo Mori. (2011) A Review of the Management of Gastric Acid-Related Diseases: Focus on Rabeprazole. Clinical Medicine. Gastroenterology 4, pages CGast.S5133.
Crossref
Thomas O. Kovacs, James W. Freston, Marian M. Haber, Stuart Atkinson, Barbara Hunt & David A. Peura. (2009) Long-Term Quality of Life Improvement in Subjects with Healed Erosive Esophagitis: Treatment with Lansoprazole. Digestive Diseases and Sciences 55:5, pages 1325-1336.
Crossref
Claudine M. Baldwin & Susan J. Keam. (2009) Rabeprazole. Drugs 69:10, pages 1373-1401.
Crossref
Fabio Pace, Franco Bazzoli, Roberto Fiocca, Francesco Di Mario, Vincenzo Savarino, Sergio Vigneri & Nimish Vakil. (2009) The Italian validation of the Montreal Global definition and classification of gastroesophageal reflux disease. European Journal of Gastroenterology & Hepatology 21:4, pages 394-408.
Crossref
Ilias Kantas, Dimitrios G. Balatsouras, Nikolaos Kamargianis, Michael Katotomichelakis, Maria Riga & Vasilis Danielidis. (2008) The influence of laryngopharyngeal reflux in the healing of laryngeal trauma. European Archives of Oto-Rhino-Laryngology 266:2, pages 253-259.
Crossref
R.J. Ali & H.R. Dalton. 2009. 573 587 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.